Safety and efficacy of memantine and trazodone versus placebo for motor neuron disease (MND SMART): stage two interim analysis from the first cycle of a phase 3, multiarm, multistage, randomised, adaptive platform trial

https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(24)00326-0/fulltext?dgcid=hubspot_email_infocusalerts-neurology_feature&utm_campaign=infocusalerts-neurology&utm_medium=email&_hsenc=p2ANqtz-844UG1Bd-3gaT0CqpZFosJsSQCF98c6JAvt2cJVaetM5XGSnnc_dWiynXYzogDHYyIWINKSPYn-_UQOgl9UvSMBdb7Tg&_hsmi=335245262&utm_content=335007849&utm_source=hs_email